Adjuvant Sequencing

Adjuvant Sequencing is a therapeutic strategy in oncology that refers to the structured temporal administration of immunotherapeutic agents following primary cancer treatment to maximize immune-mediated tumor control while minimizing interference with initial therapy efficacy.

10

Publications

438

Citations

102

Authors

63

Institutions

Publications per year

2017–2026

4

Authors

102

  1. MD
    Marc D. Schwartz

    Georgetown University, United States

    1 publications · 12 citations

    1

    h-index

  2. KS
    Kathy S. Albain

    Loyola University Chicago, United States

    1 publications · 25 citations

    1

    h-index

  3. SE
    Stephanie E. Combs

    Heidelberg University, Germany

    1 publications · 67 citations

    1

    h-index

  4. JD
    Jason D. Wright

    Columbia University, United States

    1 publications · 13 citations

    1

    h-index

  5. AS
    Ali Sak

    University of Duisburg-Essen, Germany

    1 publications · 67 citations

    1

    h-index

1–5 of 102

Venues

  1. Gynecologic Oncology

    2 publications · 46 citations

    2

    h-index

  2. Breast Cancer Research and Treatment

    1 publications · 12 citations

    1

    h-index

  3. Oncotarget

    1 publications · 14 citations

    1

    h-index

  4. The Oncologist

    1 publications · 31 citations

    1

    h-index

  5. European Journal of Cancer

    1 publications · 67 citations

    1

    h-index

1–5